期刊文献+

液相色谱-质谱法测定替考拉宁在重症感染患者血浆中的浓度 被引量:7

Determination the concentration of teicoplanin in human plasma of patients with severe infenction by liquid chromatography tandem mass spectrometry
原文传递
导出
摘要 目的建立液相色谱-质谱联用法(LC-MS/MS)测定人血浆中替考拉宁的浓度。方法人血浆样品用甲醇沉淀蛋白后,选用Agilent Eclipse Plus C_18(2.1 mm×100 mm,3.5μm)色谱柱,以甲醇-10 mmol·L^(-1)醋酸铵溶液(均含0.1%甲酸)85∶15为流动相,流速为0.25 m L·min^(-1),柱温为25~℃,用电喷雾离子化源,正离子方式,多反应监测(MRM)扫描方式进行监测,用于定量分析的离子反应分别为m/z 1880.1→m/z 1563.0(替考拉宁)和m/z 748.8→m/z158.1(内标克拉霉素)。考察其专属性、标准曲线与定量下限、精密度与回收率、基质效应和稳定性。结果血浆中替考拉宁的标准曲线方程为y=1.63×10^(-2)x-2.95×10^(-3)(r=0.996 3),在0.10~20.00μg·m L^(-1)内线性关系良好,定量下限为0.10μg·m L^(-1);质控样品的准确度在93.56%~105.12%;日内、日间RSD均小于15%;提取回收率80.32%~88.28%。基质效应为91.78%~108.56%。结论该方法快速、灵敏、准确,专属性强,重复性好,适用于人血浆中替考拉宁浓度的测定,可应用于替考拉宁的血药浓度检测和药物动力学研究。 Objective To develop a liquid chromatography tandem mass spectrometry( LC -MS/MS) method for determination of s teicoplanin in human plasma. Methods The plasma samples were precipitated by methnaol, then the supernatant were separated on Eclipse Plus C1scolumn (2. 1 mm× 100 mm, 3. 5 μm) and eluted with methnaol - 10 mmol·L -1 ammonium acetate(85: 15, v/v, containing 0. 1% formic acid) , and the column temperature was 25 ℃. Detection of the analyte was achieved using positive ion electrospray ionization (ESI) in the multiple reaction monitoring (MRM) mode. The MS/MS ion transitions monitored were m/z 1880. 1→m/z 1563.0, m/z→748.8 m/z 158.1 for teicoplaninand internal standard, respectively. The specificity, standard curve and lower limitation of quantitation, precision and recovery rate, stability and ma- trix effect were investigated. Results The linear regression equation was y = 1.63× 10-2x -2.95 × 10-3(r =0. 9963). The linear range of teico- planin was 0. 10 - 20. 00μg·mL-1, with the lower limit of quantitation (LLOQ) of 0. 10 μg · mL-1. The accuracy was 93.56% - 105.12%. Intraday and inter - dayrelative standard deviations were both below 15%. The absolute recovery in plasma was 80. 32% -88.28%. Thematrix effect was 91.78% - 108.56%. Conclusion The established method is rapid, sensitive,accurate, specific and reliable, and it is suitable for the determination of teicoplanin in human plasma and pharmacokinetic study.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2018年第5期572-575,共4页 The Chinese Journal of Clinical Pharmacology
基金 国家科技重大专项项目-老年病新药临床技术平台基金资助项目(2013ZX09303005) 浙江省自然科学基金资助项目(LQ15H310003) 浙江省老年医学重点实验室开放基金资助项目(2014-01)
关键词 替考拉宁 液相色谱-质谱联用法 血药浓度 药物动力学 teieoplanin liquid chromatography tandem mass spectrometry plasma drug concentration pharmacokinetics
  • 相关文献

参考文献4

二级参考文献35

  • 1陆红,张朴,李家泰.抗生素89-07与庆大霉素动物体内药代动力学比较研究[J].中国抗生素杂志,1995,20(6):434-438. 被引量:22
  • 2Biedenbach DJ, Bell JM, Sader HS,et al. Antimicrobial susceptibility of Gram - positive bacterial isolates from the Asia - Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: A sentry program report (2003 -2004) [J]. Int J Antimicrob Agents ,2007 ;30 : 143 - 149.
  • 3Deshpande LM, Fritsche TR, Moet GJ, et al . Antimicrobial resistance and molecular epidemiology of vancomycin - resistant enterococci from North America and Europe: A report from the sentry antimicrobial surveillance program[ J]. Diagn Microbiol Infect Dis ,2007 ;58:163 - 170.
  • 4Shea KW, Cunha BA. Teicoplanin[ J]. Med Clin North Am, 1995 ;79 : 833 - 844.
  • 5Falcoz C, Ferry N, Pozet N, et al . Pharmacokinetics of teicoplanin in renal failure[ J ]. Antimicrob Agents Chemother, 1987 ;31 : 1255 - 1262.
  • 6Guay DRP, Awni WM, Halstenson CE,et al. Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing [ J ]. Antimicrob Agents Chemother, 1989; 33:2012-2015.
  • 7Bonati M, Traina GL, Rosina R,et al. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment[ J ]. J Antimicrob Chemother, 1988;21 ( Suppl. A ) : S29 -S37.
  • 8Traina GL, Gentile MG, Fellin G,et al. Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis [ J ]. Eur J Clin Pharmacol,1986;31:501 - 504.
  • 9Brouard R J, Kapusnik JE, Gambertoglio JG, et al . Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis [ J ]. Clin Pharmacol Ther, 1989;45:674 - 681.
  • 10Hoffler D, Koeppe P, Naumann E ,et al. Pharmaeokinetics of teieoplanin in hemodialysis patients [ J ]. Infection, 1991 ; 19 : 324 - 327.

共引文献52

同被引文献49

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部